B CELL ALL
Clinical trials for B CELL ALL explained in plain language.
Never miss a new study
Get alerted when new B CELL ALL trials appear
Sign up with your email to follow new studies for B CELL ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple drug make CAR-T therapy safer?
Disease control OngoingThis study tests whether the drug anakinra can prevent or reduce severe side effects like brain problems and cytokine release syndrome caused by CAR-T cell therapy. About 62 adults with certain B-cell blood cancers who are getting CAR-T treatment will receive anakinra. The goal i…
Matched conditions: B CELL ALL
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
Donor immune cells show promise against returning blood cancers
Disease control OngoingThis early-phase study tests a new treatment for people with certain blood cancers (lymphoma or leukemia) that have returned after a stem cell transplant. Researchers take immune cells called T cells from the original stem cell donor, modify them to recognize and attack cancer ce…
Matched conditions: B CELL ALL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC